The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
In a short-term perspective, the company has interesting fundamentals.
UnitedHealth Group accounts for 5.13 % of our USA Portfolio. A trade is currently open since 11/02/2015 with a purchase price of $ 119.36. Discover the other 19 stocks of the USA portfolio managed by the 4-traders portfolio management team.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Historically, the company has been releasing figures that are above expectations.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Analysts covering this company mostly recommend stock overweighting or purchase.
The tendency within the weekly time frame is positive above the technical support level at 192.52 USD
Stock prices approach a strong long-term resistance in weekly data at USD 226.78.
Technically, the stock approaches a strong medium-term resistance at USD 228.17.